Mental Health Clinics in Loysburg, PA Accepting Medicare
2 Mental Health Clinics found. Showing 1 - 2
 Alternative Community Resource Program, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 217 Nbc Dr, Loysburg, PA 16659 Phone: 814-535-2277 |
Alternative Community Resource Program, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 152 Nbc Dr, Loysburg, PA 16659 Phone: 814-535-2277 |
News Archive
UTSA BRAVe program to benefit active-duty military soldiers and veterans
The University of Texas at San Antonio will launch a new program aimed at boosting student engagement and retention.
Study determines mechanisms underlying abnormal development of nervous system in Hirschsprung disease
Ankush Gosain, MD, PhD, of Le Bonheur Children's Hospital and the University of Tennessee Health Science Center has focused his research on determining the mechanisms underlying abnormal development of the enteric nervous system in Hirschsprung disease.
Curemark commences clinical trial enrollment for CM-AT autism treatment at two more sites
Curemark, LLC,, a drug research and development company focused on the treatment of neurological diseases, announced that the company has opened clinical trial enrollment for CM-AT, its autism treatment, at the University of Pittsburgh and the Alexian Brothers Behavioral Health Hospital in Hoffman Estates, Illinois, near Chicago. A total of 12 sites nationwide are recruiting patients for CM-AT Phase III clinical trials.
Cryoablation may be safer alternative for stopping abnormal electrical patterns
Freezing abnormal electrical pathways in the hearts of young patients may be a safer alternative to zapping them with powerful radiofrequency probes in order to treat tachycardias and other arrhythmias, according to a new study in the April 5, 2005, issue of the Journal of the American College of Cardiology.
Watson Pharmaceuticals receives FDA approval for generic Accuneb
Watson Pharmaceuticals, Inc. has announced that it has received final approval from the United States (U.S.) Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for albuterol sulfate inhalation solution in the 0.021% (base) and 0.042% (base) strengths.
› Verified 1 days ago